Congressman Auchincloss probes corruption of healthcare executives in the Trump Administration
Washington, D.C. — Yesterday, Congressman Jake Auchincloss (D-MA) sent letters calling on the boards of health companies True Medicine (TrueMed) and Main Street Health to provide information about conflicts of interest regarding their founders’ roles as special government employees overseeing health policy for the Trump administration: Calley Means of TrueMed, and Brad Smith of Main Street Health.
Mr. Means currently serves as a White House Advisor and as a Special Government Employee detailed to Health and Human Services Secretary Robert F. Kennedy Jr. As a leading policy-maker behind the Trump Administration’s “Make America Healthy Again” (MAHA) initiative, Mr. Means has significant influence in both regulation and legislation.
Mr. Smith served as the head of the Department of Government Efficiency (DOGE) at the Department of Health and Human Services (HHS) until his reported departure on May 29, 2025. In this position, Mr. Smith was reportedly the primary official responsible for planning and implementing the major reduction-in-force (RIF) at HHS.
In these letters, Auchincloss raises concerns that, as special government employees, neither Mr. Means nor Mr. Smith were required to recuse themselves from their private business interests or obtain ethics waivers. Auchincloss cites concerning instances of self-dealing:
- Mr. Means’ TrueMed creates partnerships with businesses to sell health and wellness products, many of which are not FDA-approved. TrueMed offers “letters of medical necessity” (LMNs) that enable patients to use pre-tax dollars from their Health Savings Accounts (HSA) to purchase these products. The Executive Order establishing the MAHA commission ordered health agencies to promote this application of HSAs, ultimately suggesting increased revenue for companies like TrueMed. The ‘One Big, Beautiful Bill’ also promotes the use of HSAs.
- Mr. Smith’s Main Street Health’s biggest investors are regulated by or transact with the Center for Medicare and Medicaid (CMS), including the largest Medicare Advantage Organizations (MAOs): UnitedHealthcare, Centene, CVS Health Ventures, Elevance, and Humana. These MAOs benefited from the Administration’s reduction in oversight and increase in reimbursement, as well as from Mr. Smith’s ability to win favor with CMS by protecting personnel from RIFs .
Auchincloss has called on the boards of TrueMed and Main Street Health to explain the apparent conflicts of interest involving their executives and the steps they took internally to prevent self-dealing, as their founders gained control over our nation’s public health agencies.
Full copies of the letters can be found below:
Letter to Calley Means
Letter to True Medicine
Letter to Main Street Health
###